EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the anti‐inflammatory effect of 1,4‐dihydropyridine derivatives

Bruno Matheus Facchin, Tainá Larissa Lubschinski, Yeo Jim Kinoshita Moon, Paula Giarola Fragoso de Oliveira, Bianca Klafke Beck, Ziliani da Silva Buss, Luiz Antonio Escorteganha Pollo, Maique Weber Biavatti, Louis Pergaud Sandjo, Eduardo Monguilhott Dalmarco iD

Fundamental & Clinical Pharmacology · 2024-02 · 38 (1) · 168-182

DOI: 10.1111/fcp.12945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 09.08.2023. Verfasst von Bruno Matheus Facchin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Analysis, Universidade Federal de Santa Catarina, Florianópolis, Brazil. Hauptthemen laut MEDLINE: Interleukin-10, Interleukin-6, Dihydropyridines. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Conselho Nacional de Desenvolvimento Científico e Técnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Inflammation is a physiological event that protects the organism against different factors that lead to loss of tissue homeostasis. Dihydropyridine (DHP) derivatives are heterocyclic compounds known for their different biological activities, including anti‐inflammatory activities.

Objective

To evaluate the anti‐inflammatory activity of 1,4‐dihydropyridine (1,4‐DHP) derivatives using anti‐inflammatory models in vitro, in RAW264.7 cells induced by lipopolysaccharide (LPS) and in vivo using the acute lung injury (ALI) model in mice.

Results

Fifteen compounds derived from 1,4‐DHP were tested in RAW264.7 cells for their cytotoxic effect and cell viability. Thereafter, only the six compounds that showed the highest cell viability were tested for the production or inhibition of the pro‐inflammatory cytokine interleukin 6 (IL‐6). The best compound (compound 4) was tested for its anti‐inflammatory effects in vitro and in vivo, showing inhibition of nitric oxide (NO), pro‐inflammatory cytokines, increased phagocytic activity, and an increase in IL‐10 in vitro. In in vivo tests, compound 4 also reduces the levels of NO, myeloperoxidase (MPO) activity, leukocyte migration, and exudation, as well as reducing the levels of tumor necrosis factor‐alpha (TNF‐α) and IL‐6 and preventing the loss in the lung architecture.

Conclusion

This compound showed important anti‐inflammatory activity, with a significant ability to reduce the production of pro‐inflammatory mediators and increase the phagocytic activity of macrophages and anti‐inflammatory mediator secretion (IL‐10). These findings led us to hypothesize that this compound can repolarize the macrophage response to an anti‐inflammatory profile (M2). Moreover, it was also able to maintain its anti‐inflammatory activity in vivo experiments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10Interleukin-6DihydropyridinesMiceAnimalsCytokinesAnti-Inflammatory AgentsTumor Necrosis Factor-alphaLipopolysaccharidesNitric Oxide

Stichwörter der Autor:innen

1,4-dihydropyridinesanti-inflammatorycytokineslipopolysaccharidemacrophagesnitric oxide

Substanzen

1,4-dihydropyridineInterleukin-10Interleukin-6CytokinesAnti-Inflammatory AgentsTumor Necrosis Factor-alphaLipopolysaccharidesNitric OxideDihydropyridines

Autor:innen und Institutionen

  • Department of Clinical Analysis, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
  • Department of Pharmaceutical Sciences, Universidade Federal de Santa Catarina, Florianópolis, Brazil.
  • Department of Chemistry, Universidade Federal de Santa Catarina, Florianópolis, Brazil.

ORCID-Profile: Eduardo Monguilhott Dalmarco

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Conselho Nacional de Desenvolvimento Científico e Técnológico
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Facchin, B. M., Lubschinski, T. L., Moon, Y. J. K., de Oliveira, P. G. F., Beck, B. K., da Silva Buss, Z., Pollo, L. A. E., Biavatti, M. W., Sandjo, L. P., & Dalmarco, E. M. (2024). Evaluation of the anti‐inflammatory effect of 1,4‐dihydropyridine derivatives. Fundamental & Clinical Pharmacology, 38(1), 168-182. https://doi.org/10.1111/fcp.12945

Vancouver

Facchin BM, Lubschinski TL, Moon YJK, de Oliveira PGF, Beck BK, da Silva Buss Z, et al. Evaluation of the anti‐inflammatory effect of 1,4‐dihydropyridine derivatives. Fundamental & Clinical Pharmacology. 2024;38(1):168-182. doi:10.1111/fcp.12945

BibTeX
@article{Facchin2024,
  author = {Facchin, Bruno Matheus and Lubschinski, Tainá Larissa and Moon, Yeo Jim Kinoshita and de Oliveira, Paula Giarola Fragoso and Beck, Bianca Klafke and da Silva Buss, Ziliani and Pollo, Luiz Antonio Escorteganha and Biavatti, Maique Weber and Sandjo, Louis Pergaud and Dalmarco, Eduardo Monguilhott},
  title = {Evaluation of the anti‐inflammatory effect of 1,4‐dihydropyridine derivatives},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2024},
  volume = {38},
  number = {1},
  pages = {168--182},
  doi = {10.1111/fcp.12945}
}
Kostenlos starten →